Abstract:Uncovering the stimulus-response histories that give rise to cell fates and behaviors is an area of great interest in developmental biology, tissue engineering, and regenerative medicine. A comprehensive accounting of cell experiences that lead to the development of organs and tissues can help us to understand developmental anomalies that may underly disease. Perhaps more provocatively, such a record can also reveal clues as to how to drive cell collective decision-making processes, which may yield predictable cell-based therapies or facilitate production of tissue substitutes for transplantation or in vitro screening of prospective therapies to mitigate disease. Toward this end, various methods have been applied to molecularly trace developmental trajectories and record interaction histories of cells. Typical methods involve artificial gene circuits based on recombinases that activate a suite of fluorescent reporters or CRISPR-Cas9 genome writing technologies whose nucleic acid-based record keeping serves to chronicle cell-cell interactions or past exposure to stimuli of interests. Exciting expansions of the synthetic biology toolkit with artificial receptors that permit establishment of defined input-to-output linkages of cell decision-making processes opens the door to not only record cell-cell interactions, but to also potentiate directed manipulation of the outcomes of such interactions via regulation of carefully selected transgenes. Here, we combine CRISPR-based strategies to genetically and epigenetically manipulate cells to express components of the synthetic Notch receptor platform, a widely used artificial cell signaling module. Our approach gives rise to the ability to conditionally record interactions between human cells, where the record of engagement depends on expression of a state-specific marker of a subset of cells in a population. Further, such signal-competent interactions can be used to direct differentiation of human embryonic stem cells toward pre-selected fates based on assigned synNotch outputs. We also implemented CRISPR-based manipulation of native gene expression profiles to bias outcomes of cell engagement histories in a targeted manner. Thus, we present a useful strategy that gives rise to both state-specific recording of cell-cell interactions as well as methods to intentionally influence products of such cell-cell exchanges.

Engineering transcriptional regulation for cell-based therapies

Programmable synthetic receptors: the next-generation of cell and gene therapies.

Modular design of synthetic receptors for programmed gene regulation in cell therapies

Clinically-driven design of synthetic gene regulatory programs in human cells

Enhancing cell‐based therapies with synthetic gene circuits responsive to molecular stimuli

Transcription control engineering and applications in synthetic biology

Rewiring of endogenous signaling pathways to genomic targets for therapeutic cell reprogramming

Regulatory Considerations for Genome-Edited T-cell Therapies

Engineering Natural Molecule-Triggered Genetic Control Systems for Tunable Gene- and Cell-Based Therapies

A synthetic transcription platform for programmable gene expression in mammalian cells

Small-molecule inducible transcriptional control in mammalian cells

Therapeutic applications of cell engineering using mRNA technology

Manipulating gene expression levels in mammalian cell factories: An outline of synthetic molecular toolboxes to achieve multiplexed control

Engineered poly(A)-surrogates for translational regulation and therapeutic biocomputation in mammalian cells

Multidimensional control of therapeutic human cell function with synthetic gene circuits

Transcription Activator-Like Effector Hybrids for Conditional Control and Rewiring of Chromosomal Transgene Expression

Regulation of CAR transgene expression to design semiautonomous CAR-T

Rapid discovery of synthetic DNA sequences to rewrite endogenous T cell circuits

Use of CRISPRoff and synthetic Notch to modulate and relay endogenous gene expression programs in engineered cells

Machine-guided design of cell-type-targeting cis-regulatory elements

Synthetic Therapeutic Gene Circuits in Mammalian Cells